Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Lung Cancer treatment details. Chemotherapy. Radiation. Wisconsin Institute for Medical Research, Madison, WI, United States

Survival: 15.3 months
Toxicity Grade: 5
Treatments: Chemotherapy
Country: United States
City/State/Province: Madison, WI
Hospital: Wisconsin Institute for Medical Research
Journal: Link
Date: 1/2012

This phase III study involved non–small-cell lung cancer patients who were divided into two separate treatment groups. Group A consisted of 275 patients with a median age of 63 years and 62% male. Group B had 271 patients with a median age of 63 years and 60% male.

Patients in group A were treated with radiation and the chemotherapy drugs paclitaxel and carboplatin.
Group B was treated with radiation, paclitaxel, carboplatin, and the biologic therapy agent thalidomide.

Treatment–related deaths were reported in group A due to thromboembolism (blood clot) and infection.

In group B, treatment-related deaths due to thromboembolism (blood clot), pneumonia, and cardiac ischemia (reduced blood flow).

The median overall survival rate for groups A and B was 15.3 and 16.0 months, respectively.

Some of the authors have served as consultants for several pharmaceutical companies.

Correspondence: Dr. Tien Hoang; email:

E-mail to a Friend Email Physician More Information